DERMATOLOGIC EXAMINATION ABNORMAL

This adverse event was reported 22 times

These drugs are most commonly taken by patients reporting DERMATOLOGIC EXAMINATION ABNORMAL:

# Drug Count
0 USTEKINUMAB 7
1 ETANERCEPT 5
2 METHOTREXATE SODIUM 5
3 METHOTREXATE 4
4 FINGOLIMOD HCL 3
5 CANDESARTAN 2
6 EZETIMIBE AND SIMVASTATIN 2
7 FAMOTIDINE 2
8 FULVESTRANT 2
9 RIOCIGUAT 2
See all common drugs associated with DERMATOLOGIC EXAMINATION ABNORMAL

DERMATOLOGIC EXAMINATION ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SPESOLIMAB 1 0.0025
1 TELMISARTAN AND HYDROCHLOROTHIAZIDE 1 0.0004
2 CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE 1 0.0003
3 BETAMETHASONE DIPROPIONATE 1 0.0001
4 EZETIMIBE AND SIMVASTATIN 2 0.0001
5 USTEKINUMAB 7 0.0001
6 ISONIAZID 1 0.0001
7 RIOCIGUAT 2 0.0001
8 FULVESTRANT 2 0.0001
9 CANDESARTAN 2 0.0001
See all drugs enriched for association with DERMATOLOGIC EXAMINATION ABNORMAL